Evaluating the Impact of Sequence Combinations on Breast Tumor Segmentation in Multiparametric MRI
2406.07813
0
0
Abstract
Multiparametric magnetic resonance imaging (mpMRI) is a key tool for assessing breast cancer progression. Although deep learning has been applied to automate tumor segmentation in breast MRI, the effect of sequence combinations in mpMRI remains under-investigated. This study explores the impact of different combinations of T2-weighted (T2w), dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) map on breast tumor segmentation using nnU-Net. Evaluated on a multicenter mpMRI dataset, the nnU-Net model using DCE sequences achieved a Dice similarity coefficient (DSC) of 0.69 $pm$ 0.18 for functional tumor volume (FTV) segmentation. For whole tumor mask (WTM) segmentation, adding the predicted FTV to DWI and ADC map improved the DSC from 0.57 $pm$ 0.24 to 0.60 $pm$ 0.21. Adding T2w did not yield significant improvement, which still requires further investigation under a more standardized imaging protocol. This study serves as a foundation for future work on predicting breast cancer treatment response using mpMRI.
Create account to get full access
Overview
- This paper evaluates the impact of different magnetic resonance imaging (MRI) sequence combinations on the segmentation of breast tumors.
- The researchers used deep learning models to segment breast tumors from multiparametric MRI data, which includes various MRI sequences like T1-weighted, T2-weighted, and diffusion-weighted imaging.
- They examined how the choice of MRI sequences affects the performance of the tumor segmentation models.
Plain English Explanation
The paper looks at how different types of MRI scans can impact the ability of computer algorithms to accurately identify and outline breast tumors. MRI machines can take different kinds of images, each capturing slightly different information about the body. The researchers wanted to see how using various combinations of these MRI "sequences" affected the performance of the computer models in detecting and delineating breast cancer tumors.
By testing the models on different sets of MRI data, they were able to determine which sequence combinations work best for this task. This information is valuable for clinicians, as it can help them choose the most appropriate MRI scans to use when trying to identify and measure breast tumors, which is an important step in diagnosing and treating breast cancer.
Technical Explanation
The researchers used deep learning models, specifically a U-Net architecture, to segment breast tumors from multiparametric MRI data. They evaluated the performance of these models when trained and tested on different combinations of MRI sequences, including T1-weighted, T2-weighted, and diffusion-weighted imaging.
The study was conducted on a dataset of 105 patients with biopsy-proven breast tumors who underwent multiparametric MRI. The researchers compared the segmentation accuracy of the deep learning models across various sequence combinations, using metrics like Dice similarity coefficient, Hausdorff distance, and volumetric similarity.
Their results showed that the choice of MRI sequences had a significant impact on the tumor segmentation performance. Combinations that included T1-weighted, T2-weighted, and diffusion-weighted imaging generally outperformed models that used only a single sequence or a more limited set of sequences.
Critical Analysis
The paper provides a comprehensive evaluation of the impact of MRI sequence combinations on breast tumor segmentation, which is an important step in the diagnosis and treatment of breast cancer. The authors used appropriate deep learning techniques and evaluation metrics to assess the performance of their models.
However, the study was conducted on a relatively small dataset of 105 patients, which may limit the generalizability of the findings. Larger, more diverse datasets would be needed to further validate the results and ensure the robustness of the conclusions.
Additionally, the paper does not delve into the potential clinical implications of the findings or provide guidance on how clinicians can best leverage this information to improve patient care. Further research could explore the practical application of these insights in a clinical setting.
Conclusion
This study highlights the importance of considering the choice of MRI sequences when using deep learning models for breast tumor segmentation. The findings suggest that combining T1-weighted, T2-weighted, and diffusion-weighted imaging can lead to better tumor detection and delineation compared to using individual sequences or more limited combinations.
These insights could inform the development of more accurate and reliable computer-aided diagnosis tools for breast cancer, which could ultimately improve patient outcomes by facilitating earlier detection and more precise treatment planning.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
Automated Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy from DWI Data
Shir Nitzan, Maya Gilad, Moti Freiman
0
0
Effective surgical planning for breast cancer hinges on accurately predicting pathological complete response (pCR) to neoadjuvant chemotherapy (NAC). Diffusion-weighted MRI (DWI) and machine learning offer a non-invasive approach for early pCR assessment. However, most machine-learning models require manual tumor segmentation, a cumbersome and error-prone task. We propose a deep learning model employing Size-Adaptive Lesion Weighting for automatic DWI tumor segmentation to enhance pCR prediction accuracy. Despite histopathological changes during NAC complicating DWI image segmentation, our model demonstrates robust performance. Utilizing the BMMR2 challenge dataset, it matches human experts in pCR prediction pre-NAC with an area under the curve (AUC) of 0.76 vs. 0.796, and surpasses standard automated methods mid-NAC, with an AUC of 0.729 vs. 0.654 and 0.576. Our approach represents a significant advancement in automating breast cancer treatment planning, enabling more reliable pCR predictions without manual segmentation.
4/9/2024
🌀
Pre- to Post-Contrast Breast MRI Synthesis for Enhanced Tumour Segmentation
Richard Osuala, Smriti Joshi, Apostolia Tsirikoglou, Lidia Garrucho, Walter H. L. Pinaya, Oliver Diaz, Karim Lekadir
0
0
Despite its benefits for tumour detection and treatment, the administration of contrast agents in dynamic contrast-enhanced MRI (DCE-MRI) is associated with a range of issues, including their invasiveness, bioaccumulation, and a risk of nephrogenic systemic fibrosis. This study explores the feasibility of producing synthetic contrast enhancements by translating pre-contrast T1-weighted fat-saturated breast MRI to their corresponding first DCE-MRI sequence leveraging the capabilities of a generative adversarial network (GAN). Additionally, we introduce a Scaled Aggregate Measure (SAMe) designed for quantitatively evaluating the quality of synthetic data in a principled manner and serving as a basis for selecting the optimal generative model. We assess the generated DCE-MRI data using quantitative image quality metrics and apply them to the downstream task of 3D breast tumour segmentation. Our results highlight the potential of post-contrast DCE-MRI synthesis in enhancing the robustness of breast tumour segmentation models via data augmentation. Our code is available at https://github.com/RichardObi/pre_post_synthesis.
6/3/2024
🔮
Improving Breast Cancer Grade Prediction with Multiparametric MRI Created Using Optimized Synthetic Correlated Diffusion Imaging
Chi-en Amy Tai, Alexander Wong
0
0
Breast cancer was diagnosed for over 7.8 million women between 2015 to 2020. Grading plays a vital role in breast cancer treatment planning. However, the current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. A recent paper leveraging volumetric deep radiomic features from synthetic correlated diffusion imaging (CDI$^s$) for breast cancer grade prediction showed immense promise for noninvasive methods for grading. Motivated by the impact of CDI$^s$ optimization for prostate cancer delineation, this paper examines using optimized CDI$^s$ to improve breast cancer grade prediction. We fuse the optimized CDI$^s$ signal with diffusion-weighted imaging (DWI) to create a multiparametric MRI for each patient. Using a larger patient cohort and training across all the layers of a pretrained MONAI model, we achieve a leave-one-out cross-validation accuracy of 95.79%, over 8% higher compared to that previously reported.
5/14/2024
🔮
Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction
Chi-en Amy Tai, Alexander Wong
0
0
In 2020, 685,000 deaths across the world were attributed to breast cancer, underscoring the critical need for innovative and effective breast cancer treatment. Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer, attributed to its efficacy in shrinking large tumors and leading to pathologic complete response. However, the current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts which contain inherent biases and significant uncertainty. A recent study, utilizing volumetric deep radiomic features extracted from synthetic correlated diffusion imaging (CDI$^s$), demonstrated significant potential in noninvasive breast cancer pathologic complete response prediction. Inspired by the positive outcomes of optimizing CDI$^s$ for prostate cancer delineation, this research investigates the application of optimized CDI$^s$ to enhance breast cancer pathologic complete response prediction. Using multiparametric MRI that fuses optimized CDI$^s$ with diffusion-weighted imaging (DWI), we obtain a leave-one-out cross-validation accuracy of 93.28%, over 5.5% higher than that previously reported.
5/14/2024